Biohub unveils AI world model for protein biology, aiming to reshape drug discovery
Biohub has launched an open-source AI toolkit aimed at revolutionizing drug discovery through advanced protein design. The toolkit includes three models, with the ESM Atlas covering 6.8 billion proteins, significantly expanding the scope of protein research. This initiative is backed by a $500 million investment and is intended to serve as public infrastructure for the field of protein biology.
- ▪Biohub's new AI suite includes three models designed for protein mapping, prediction, and design.
- ▪The ESM Atlas encompasses 6.8 billion proteins, far exceeding the human body's 20,000 protein-coding genes.
- ▪The models have already shown practical results in laboratory tests, successfully designing proteins with therapeutic-level affinity.
Opening excerpt (first ~120 words) tap to expand
Biohub unveils AI world model for drug discovery, enhancing protein design Mark Zuckerberg and Priscilla Chan's nonprofit releases open-source protein AI suite covering 6.8 billion proteins, backed by $500 million in funding. Share Add us on Google by Editorial Team May. 27, 2026 window.sevioads = window.sevioads || []; var sevioads_preferences = []; sevioads_preferences[0] = {}; sevioads_preferences[0].zone = "01f21ccf-2092-46b1-9ac7-8c44cc782e0f"; sevioads_preferences[0].adType = "native"; sevioads_preferences[0].inventoryId = "c5700508-581b-472c-8fdd-a931cdbfc8e1"; sevioads_preferences[0].accountId = "1e47efc1-ec2d-4fca-a8b9-354e249e5095"; sevioads.push(sevioads_preferences); Biohub, the nonprofit biomedical research organization co-founded by Mark Zuckerberg and Priscilla Chan, just…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Crypto Briefing.
Discussion
0 commentsMore from Crypto Briefing
